Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06880731 · ClinicalTrials.gov registry record · NA

Training Inner Speech in Children With Developmental Language Disorder

A NA study of Developmental Language Disorder, sponsored by MGH Institute of Health Professions.

Recruiting
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT06880731 is a NA study of Developmental Language Disorder that is actively recruiting participants, run by MGH Institute of Health Professions. The registered enrollment target is 75 participants, below the 178-participant average among 17 other Developmental Language Disorder trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06880731, a NA study of Developmental Language Disorder, is actively recruiting participants, sponsored by MGH Institute of Health Professions.

RECRUITING
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

The complex and unclear relationship between language and executive function (EF) creates barriers to developing effective interventions for children with developmental language disorder (DLD) whose language difficulties often co-occur with impaired EF. Children and adults with typical language development (TD) facilitate their EF by using self-directed language, or verbal mediation, to guide conscious reflection and override habitual behaviors. Conversely, children with DLD do not use verbal mediation to support EF efficiently or effectively. Promising evidence suggests that language-based training can shape verbal mediation and improve EF task performance in children with TD, which makes it pertinent to determine whether verbal mediation training benefits children with DLD. Specifically, modeling interventions have been shown to promote learning of language forms without taxing the cognitive resources required for learning such as attention or working memory, which are known to be impaired among children with DLD. The long-term goal of the proposed work is to optimize intervention outcomes for children with DLD by elucidating the complex relationship between language and executive functions. The objective of this project is to determine the impact of modeling verbal mediation on shifting task performance in school-aged children with DLD. Shifting, also known as cognitive flexibility, is the ability to alternate between operations or mental sets. It is an important EF because it is the pivot point between multiple goal-directed tasks when language use is critical for guiding action. Children aged 8-10 years will complete three versions of a shifting task over three phases: pre-intervention, intervention, and post-intervention. During the intervention phase, half of the participants with DLD will be exposed to a task model with verbal mediation (training), while the other half will be exposed to a silent task model (control). The investigators will determine the eff

Interventions

  • BEHAVIORAL Modeling with Verbal Mediation
  • BEHAVIORAL Modeling Only

Study Locations (1)

Massachusetts

  • MGH Institute of Health Professions - Boston

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2025-11-21
Est. Completion 2028-03
Phase NA

What the Registry Record Tells You About NCT06880731

The ClinicalTrials.gov registry entry for NCT06880731 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 178-participant average among 17 other Developmental Language Disorder trials with a reported enrollment target (58% lower). The listed sponsor is MGH Institute of Health Professions, which has 16 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Developmental Language Disorder appearing as the primary indexed condition, and to 2 interventions - of which Modeling with Verbal Mediation is the first listed.

NCT06880731 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06880731 about?

NCT06880731 is a clinical study titled "Training Inner Speech in Children With Developmental Language Disorder". The complex and unclear relationship between language and executive function (EF) creates barriers to developing effective interventions for children with developmental language disorder (DLD) whose language difficulties often co-occur with impaired EF. Children and adults with typical language deve...

What is the current status of trial NCT06880731?

This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2025-11-21. Estimated completion is 2028-03.

What conditions does trial NCT06880731 study?

This clinical trial studies the following conditions: Developmental Language Disorder.

What interventions are being tested in trial NCT06880731?

The interventions under investigation include: Modeling with Verbal Mediation (BEHAVIORAL), Modeling Only (BEHAVIORAL).

Who is sponsoring clinical trial NCT06880731?

This trial is sponsored by MGH Institute of Health Professions, which has 16 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06880731 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Developmental Language Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.